Vimarsana
Biggest News Aggregation in the World

Page 2 - Software Precertification Pilot Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Software Precertification Pilot Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Software Precertification Pilot Program Today - Breaking & Trending Today

Bill could pave the way for prescription digital therapeutics reimbursement - Vimarsana News

Bill could pave the way for prescription digital therapeutics reimbursement

Some experts assert the legislation is preemptive and may stifle innovation, while others argue it has the potential to improve patient access to meaningful healthcare.

Pear Therapeutics, Inc.: Pear Therapeutics Presents Real-World Data Showing Reduction in Healthcare Resource Utilization and Associated Costs in Adults Using Somryst at ISPOR Europe - Vimarsana News

Pear Therapeutics, Inc.: Pear Therapeutics Presents Real-World Data Showing Reduction in Healthcare Resource Utilization and Associated Costs in Adults Using Somryst at ISPOR Europe

Somryst is the only FDA-authorized prescription digital therapeutic (PDT) for the treatment of chronic insomnia Analysis demonstrated potential per-patient cost reductions over 24 months of

FDA Issues Results of its Software Precertification Pilot Program - Vimarsana News

FDA Issues Results of its Software Precertification Pilot Program

FDA launched the Pilot Program to study whether information collected at multiple points during the total life cycle of a software product could be an efficient and successful approach to assess the safety and effectiveness of medical device technologies.

Pear Therapeutics and Cove Behavioral Health to Provide Patients Access to Prescription Digital Therapeutic for the Treatment of Opioid Use Disorder - Vimarsana News

Pear Therapeutics and Cove Behavioral Health to Provide Patients Access to Prescription Digital Therapeutic for the Treatment of Opioid Use Disorder

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com
Pear Therapeutics Reports First Quarter 2022 Financial Results - Vimarsana News

Pear Therapeutics Reports First Quarter 2022 Financial Results

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com